ENTRY       D08673                      Drug
NAME        Viloxazine (INN)
FORMULA     C13H19NO3
EXACT_MASS  237.1365
MOL_WEIGHT  237.2949
CLASS       Neuropsychiatric agent
             DG03085  Selective norepinephrine reuptake inhibitor (NRI)
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG02924  UGT substrate
              DG03188  UGT1A9 substrate
              DG03187  UGT2B15 substrate
REMARK      ATC code: N06AX09
            Chemical structure group: DG00956
            Product (DG00956): D02572<US>
EFFICACY    Antidepressant, Selective noradrenaline reuptake inhibitor (NRI)
TARGET      SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
  PATHWAY   hsa04721(6530)  Synaptic vesicle cycle
METABOLISM  Enzyme: CYP2D6 [HSA:1565], UGT1A9 [HSA:54600], UGT2B15 [HSA:7366]
INTERACTION  
STR_MAP     map07027  Antidepressants
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AX Other antidepressants
                 N06AX09 Viloxazine
                  D08673  Viloxazine (INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03085  Selective norepinephrine reuptake inhibitor (NRI)
               DG00956  Viloxazine
                D08673  Viloxazine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00956  Viloxazine
                D08673  Viloxazine
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                DG00956  Viloxazine
                 D08673  Viloxazine
               DG03187  UGT2B15 substrate
                DG00956  Viloxazine
                 D08673  Viloxazine
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D08673  Viloxazine (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08673
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03085  Selective norepinephrine reuptake inhibitor (NRI)
               DG00956  Viloxazine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00956  Viloxazine
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                DG00956  Viloxazine
               DG03187  UGT2B15 substrate
                DG00956  Viloxazine
DBLINKS     CAS: 46817-91-8
            PubChem: 96025356
            LigandBox: D08673
            NIKKAJI: J16.881E
ATOM        17
            1   C8x C    19.8800  -17.5700
            2   C8x C    19.8800  -16.1700
            3   C8x C    21.0700  -15.4700
            4   C8y C    22.3300  -16.1700
            5   C8y C    22.3300  -17.5700
            6   C8x C    21.0700  -18.2700
            7   O2a O    23.5200  -18.2700
            8   C1b C    24.7800  -17.5700
            9   C1y C    25.9700  -18.2700
            10  O2a O    23.5200  -15.4700
            11  C1b C    24.7800  -16.1700
            12  C1a C    25.9700  -15.4700
            13  O2x O    27.1600  -17.5700
            14  C1x C    28.4200  -18.2700
            15  C1x C    28.4200  -19.6700
            16  N1x N    27.1600  -20.3700
            17  C1x C    25.9700  -19.6700
BOND        18
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 1
            10    4  10 1
            11   10  11 1
            12   11  12 1
            13    9  13 1
            14   13  14 1
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18    9  17 1
///
